期 |
栏目 |
标题 |
文件 |
卷 17, 编号 4 (2020) |
Reviews |
The role of atopy patch test with aeroallergens in allergic diseases diagnostics |
(Rus)
|
卷 17, 编号 2 (2020) |
Lections |
Fresh look on the urticaria problem. |
(Rus)
|
卷 17, 编号 3 (2020) |
Original studies |
Molecular allergodiagnostics capabilities in determining the indications for allergen-specific immunotherapy with house dust mites allergen and its effectiveness in atopic dermatitis patients |
(Rus)
(Eng)
|
卷 18, 编号 1 (2021) |
Letters to the editor |
Chronic urticaria in theory and practice. Experience of UCARE-centers for clinicians |
(Rus)
(Eng)
|
卷 18, 编号 3 (2021) |
Clinical practice guidelines |
Atopic dermatitis |
(Rus)
|
卷 18, 编号 3 (2021) |
Clinical practice guidelines |
Vaccination of patients with allergic disease against novel coronavirus infection: position paper of the Russian Association of Allergology and Clinical Immunology |
(Rus)
|
卷 17, 编号 3 (2020) |
Help to the practitioner |
Biological therapy of allergic diseases during the COVID-19 pandemic |
(Rus)
|
卷 19, 编号 2 (2022) |
Clinical practice guidelines |
Practical issues in the use of emollients containing filaggrin modulators in the management of patients with atopic dermatitis and xerosis: Resolution of the Expert board |
(Rus)
|
卷 19, 编号 2 (2022) |
Clinical practice guidelines |
Resolution of the Working Meeting of Experts in “Dermatology”: Possibilities of systemic therapy of atopic dermatitis with selective immunosuppressants |
(Rus)
|
卷 19, 编号 3 (2022) |
Clinical practice guidelines |
The use of Cetirizine and Levocetirizine in patients with chronic urticaria and other allergic dermatoses: issues of dosage increasing and long-term use. Resolution of the Advisory Board |
(Rus)
|
卷 20, 编号 1 (2023) |
Original studies |
The role of modern emollients in prophylaxis of atopic dermatitis exacerbation during pollination season |
|
卷 20, 编号 1 (2023) |
Reviews |
Skin microbiome and modern treatment options for complicated forms of atopic dermatitis |
|
卷 19, 编号 4 (2022) |
Case reports |
The significance of component-resolved allergy diagnostics in atopic dermatitis patients when prescribing allergen-specific immunotherapy |
|
卷 20, 编号 4 (2023) |
Original studies |
Characteristics of the molecular sensitization profiles in patients with birch pollen allergy and cross-reactive food allergy to PR-10 proteins |
(Rus)
|
卷 20, 编号 4 (2023) |
Reviews |
Diagnostic and prognostic value of biomarkers in atopic dermatitis for assessing its endotypes, phenotypes, and treatment efficacy |
(Rus)
|
卷 20, 编号 4 (2023) |
Editorial |
Moisturizers for the treatment and prophylaxis of atopic dermatitis exacerbations |
|
卷 20, 编号 2 (2023) |
Clinical practice guidelines |
Practical issues of using emollients for the prevention of exacerbations of atopic dermatitis during the flowering season: Expert resolution |
(Rus)
|
卷 21, 编号 1 (2024) |
Original studies |
The experience with subcutaneous allergen-specific immunotherapy with pollen allergens in patients with atopic dermatitis |
(Rus)
|
卷 21, 编号 1 (2024) |
Clinical practice guidelines |
Urticaria |
(Rus)
|
卷 21, 编号 1 (2024) |
Case reports |
Clinical efficacy of modern emollients in atopic dermatitis: case reports |
(Rus)
|
卷 21, 编号 2 (2024) |
Reviews |
The role of Bruton's tyrosine kinase in pathogenesis of chronic spontaneous urticaria and the prospects for the use of new treatment |
(Rus)
|
卷 21, 编号 2 (2024) |
Case reports |
Activated zinc pyrithione in topical treatment of atopic dermatitis: a case report |
|